Cadrenal Therapeutics Inc...

17.43
-1.57 (-8.26%)
At close: Mar 03, 2025, 3:59 PM
17.40
-0.17%
After-hours: Mar 03, 2025, 04:00 PM EST

Cadrenal Therapeutics Common Stock Balance Sheet Statement

Year FY23 FY22
Cash & Equivalents 8.4M 32.59K
Short-Term Investments n/a n/a
Long-Term Investments n/a n/a
Other Long-Term Assets 3.79K -526.01K
Receivables n/a n/a
Inventory n/a n/a
Other Current Assets 89.67K 695.01K
Total Current Assets 8.49M 727.6K
Property-Plant & Equipment 23.29K 44.59K
Goodwill & Intangibles n/a n/a
Total Long-Term Assets 27.08K 50.58K
Total Assets 8.52M 778.17K
Account Payables 167.32K 404.9K
Deferred Revenue n/a n/a
Short-Term Debt 21.35K 66.02K
Other Current Liabilities 638.21K 863.56K
Total Current Liabilities 826.88K 1.33M
Long-Term Debt n/a 574.69K
Other Long-Term Liabilities n/a 4.42M
Total Long-Term Liabilities n/a 4.99M
Total Liabilities 826.88K 6.33M
Total Debt 21.35K 640.71K
Common Stock 13.02K 8.19K
Retained Earnings -15.07M -6.71M
Comprehensive Income n/a n/a
Shareholders Equity 7.69M -5.55M
Total Investments n/a n/a